Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-11

Clinical Trial Update: A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users.

View source ↗

Summary

Pfizer-led trial comparing rimegepant with triptans in people with migraine using the Migraine Buddy app has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rimegepant (rimegepant)
  • Triptans (triptans)

Snippet

Sponsor: Pfizer | Conditions: Migraine | Status: COMPLETED | Results posted: 2025-08-11